Category Archives: apol

Nasdaq 100 Watch List

Below are the Nasdaq 100 companies that are within 20% of the 52-week low. This list is strictly for the purpose of researching whether or not the companies have viable business models or are about to go out of business. These companies are deemed highly speculative unless otherwise noted. -Touc

Symbol

Name Trade P/E EPS (ttm) Yield P/B % Yr Low

GENZ

Genzyme Corporation

48.50

27.65

1.75

N/A

1.68

2.99%

GILD

Gilead Sciences, Inc.

43.00

16.63

2.59

N/A

6.87

5.86%

APOL

Apollo Group, Inc.

59.27

15.80

3.75

N/A

7.81

12.28%

CEPH

Cephalon, Inc.

59.88

16.55

3.62

N/A

2.08

13.95%

Nasdaq 100 Watch List

Below are the Nasdaq 100 companies that are within 20% of the 52-week low. This list is strictly for the purpose of researching whether or not the companies have viable business models or are about to go out of business. These companies are deemed highly speculative unless otherwise noted.

Symbol

Name Price P/E EPS Yield P/B

% from Low

GENZ

Genzyme

48.78

27.81

1.75

N/A

1.68

3.59%

GILD

Gilead

42.83

16.56

2.59

N/A

6.90

5.44%

APOL

Apollo Grp

58.40

15.57

3.75

N/A

7.67

10.63%

CEPH

Cephalon

59.04

16.32

3.62

N/A

2.05

12.35%

ERTS

EA

16.72

N/A

-4.06

N/A

2.02

17.42%

ILMN

Illumina

27.88

38.78

0.72

N/A

3.40

19.71%

BIIB

Biogen

50.07

16.76

2.99

N/A

2.18

19.93%

Nasdaq 100 Watch List

The following are Nasdaq 100 members that are within 20% of the 52-week low:

  • Genzyme Corp. (GENZ) at $49.74 within 5.63%
  • Apollo Group (APOL) at $56.58 within 7.18%
  • Cephalon, Inc. (CEPH) at $58.94 within 12.16%
  • Electronic Arts (ERTS) at $16.11 within 13.13%
  • Gilead Sciences (GILD) at $46.42 within 14.28%
  • Ryanair Holdings (RYAAY) at $25.34 within 16.40%
  • Biogen Idec (BIIB) at $48.65 within 16.53%
  • Pharma. Prod. Dev. (PPDI) at $21.41 within 16.53%

Nasdaq 100 Watch List

The following are the Nasdaq 100 members that are within 20% of the 52-week low:

  • Cephalon, Inc. (CEPH) at $55.23 within 5.10%
  • Apollo Group (APOL) at $55.76 within 5.63%
  • Genzyme Corp (GENZ) at $51.07 within 8.45%
  • Gilead Sciences (GILD) at $46.56 within 14.62%
  • Ryanair Holdings (RYAAY) at $25.83 within 18.65%
  • Pharma. Prod. Dev. (PPDI) at $21.41 within 19.14%
  • First Solar Inc. (FSLR) at $120.30 within 19.23%
  • Electronic Arts (ERTS) at $17.01 within 19.45%

Nasdaq 100 Watch List

The following are the Nasdaq 100 members that are within 20% of the 52-week low:

  • Apollo Group, Inc. (APOL) at $53.86 within 2.03%
  • Cephalon, Inc. (CEPH) at $59.81 within 13.82%
  • Genzyme Corporation (GENZ) at $49.28 within 4.65%
  • Pharma. Products Dev. (PPDI) at $20.66 within 14.97%
  • Gilead Sciences, Inc. (GILD) at $47.05 within 19.51%

Nasdaq 100 Watch List

The following are the Nasdaq 100 members that are within 20% of the 52-week low:

  • Apollo Group, Inc. (APOL) at $55.99 within 1.16%
  • Cephalon, Inc. (CEPH) at $58.26 within 10.87%
  • Genzyme Corporation (GENZ) at $52.28 within 11.02%
  • Pharma. Products Dev. (PPDI) at $20.93 within 16.47%
  • Gilead Sciences, Inc. (GILD) at $46.26 within 17.50%

It is interesting to note the percentage change that has occurred in last week's Nasdaq 100 watch list. Last week's list had the following one week percentage change:

  • APOL down 1.94%
  • CEPH up 6.74%
  • GENZ up 3.32%
  • PPDI down 2.88%
  • GILD up 8.72%
  • BIIB up 8.62%
  • SRCL up 3.69%
  • AMGN up 2%

The biotech/pharma sector is moving higher. As we've stated before, these companies are very undervalued at the present time. Do your research and carefully consider the opportunities. Touc.

Nasdaq 100 Watch List

The following are the Nasdaq 100 members that are within 20% of the 52-week low:

  • Apollo Group, Inc. (APOL) at $57.10 within 3.16%
  • Cephalon, Inc. (CEPH) at $54.58 within 3.86%
  • Genzyme Corporation (GENZ) at $50.60 within 7.45%
  • Gilead Sciences, Inc. (GILD) at $42.55 within 8.08%
  • Biogen Idec Inc (BIIB) at $42.13 within 13.22%
  • Stericycle, Inc. (SRCL) at $52.37 within 18.06%
  • Amgen Inc. (AMGN) at $53.62 within 19.26%
  • Pharmaceutical Product Developm (PPDI) at $21.55 within 19.92%

The fact that all of these companies (except for APOL) are within the drug industry does not surprise me. The continued undervaluation of these companies makes them prime targets for acquisition by investors and larger drug companies. Touc.